Test of Effect of Lipid Lowering by Diet on Cardiovascular Risk (The Minnesota Coronary Survey)

The Minnesota Coronary Survey is one of the famous “negative” diet-heart trials, frequently cited by those who question the saturated-fat hypothesis — so it deserves a careful read.

Conducted in institutionalized patients, it replaced saturated fat with polyunsaturated fat and successfully lowered serum cholesterol in the treatment group. Yet over follow-up, there was no overall reduction in cardiovascular events or deaths, with only hints of benefit in younger participants. Lowering cholesterol by diet did not, in this trial, translate into fewer events.

The interpretation requires nuance. The trial’s institutional setting meant high patient turnover and short individual exposure — many participants were not on the diet long enough for an effect to accrue — and the dietary swap introduced polyunsaturated fats whose long-term effects were themselves uncertain. It is best read as a flawed, underpowered test rather than a refutation of the larger, consistent evidence (especially from drug trials) that lowering atherogenic lipoproteins reduces events.

We rate the evidence moderate-to-strong as a trial, but its negative result reflects design limitations as much as biology. It is a cautionary data point, not a counterargument to the LDL-causation evidence built on Mendelian randomization and statin trials.